143 related articles for article (PubMed ID: 7927253)
1. Specific and dose-dependent enzyme induction by omeprazole in human beings.
Rost KL; Brösicke H; Heinemeyer G; Roots I
Hepatology; 1994 Nov; 20(5):1204-12. PubMed ID: 7927253
[TBL] [Abstract][Full Text] [Related]
2. Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.
Rost KL; Brösicke H; Brockmöller J; Scheffler M; Helge H; Roots I
Clin Pharmacol Ther; 1992 Aug; 52(2):170-80. PubMed ID: 1505152
[TBL] [Abstract][Full Text] [Related]
3. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test.
Rost KL; Roots I
Clin Pharmacol Ther; 1994 Apr; 55(4):402-11. PubMed ID: 8162667
[TBL] [Abstract][Full Text] [Related]
4. The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin.
Sarich T; Kalhorn T; Magee S; al-Sayegh F; Adams S; Slattery J; Goldstein J; Nelson S; Wright J
Clin Pharmacol Ther; 1997 Jul; 62(1):21-8. PubMed ID: 9246016
[TBL] [Abstract][Full Text] [Related]
5. Four-week treatment with omeprazole increases the metabolism of caffeine.
Nousbaum JB; Berthou F; Carlhant D; Riche C; Robaszkiewicz M; Gouerou H
Am J Gastroenterol; 1994 Mar; 89(3):371-5. PubMed ID: 8122647
[TBL] [Abstract][Full Text] [Related]
6. Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment.
Rost KL; Mansmann U; Roots I
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):14-8. PubMed ID: 9021436
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole weakly inhibits CYP1A2 activity in man.
Rost KL; Fuhr U; Thomsen T; Zaigler M; Brockmöller J; Bohnemeier H; Roots I
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):567-74. PubMed ID: 10584979
[TBL] [Abstract][Full Text] [Related]
10. Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats.
Chen L; Bondoc FY; Lee MJ; Hussin AH; Thomas PE; Yang CS
Drug Metab Dispos; 1996 May; 24(5):529-33. PubMed ID: 8723732
[TBL] [Abstract][Full Text] [Related]
11. Dose dependent induction of CYP1A2 activity by omeprazole (Antra).
Rost KL; Brösicke H; Scheffler M; Roots I
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):542-3. PubMed ID: 1490825
[No Abstract] [Full Text] [Related]
12. Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans.
Partovian C; Jacqz-Aigrain E; Keundjian A; Jaillon P; Funck-Brentano C
Clin Pharmacol Ther; 1995 Sep; 58(3):257-63. PubMed ID: 7554698
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers.
Xiaodong S; Gatti G; Bartoli A; Cipolla G; Crema F; Perucca E
Ther Drug Monit; 1994 Jun; 16(3):248-50. PubMed ID: 8085279
[TBL] [Abstract][Full Text] [Related]
14. The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity.
Fontana RJ; Turgeon DK; Woolf TF; Knapp MJ; Foster NL; Watkins PB
Hepatology; 1996 Jun; 23(6):1429-35. PubMed ID: 8675160
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cytochrome P4501A1 in teleosts: sustained induction of CYP1A1 mRNA, protein, and catalytic activity by 2,3,7,8-tetrachlorodibenzofuran in the marine fish Stenotomus chrysops.
Hahn ME; Stegeman JJ
Toxicol Appl Pharmacol; 1994 Aug; 127(2):187-98. PubMed ID: 8048062
[TBL] [Abstract][Full Text] [Related]
16. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment.
Hermida J; Fernández MP; Tutor JC
Clin Lab; 2002; 48(7-8):415-9. PubMed ID: 12146576
[TBL] [Abstract][Full Text] [Related]
17. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.
Nakajima M; Yokoi T; Mizutani M; Shin S; Kadlubar FF; Kamataki T
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):413-21. PubMed ID: 7920209
[TBL] [Abstract][Full Text] [Related]
18. Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol.
Koup JR; Anderson GD; Loi CM
J Clin Pharmacol; 1998 Sep; 38(9):815-8. PubMed ID: 9753209
[TBL] [Abstract][Full Text] [Related]
19. Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects.
Asimus S; Elsherbiny D; Hai TN; Jansson B; Huong NV; Petzold MG; Simonsson US; Ashton M
Fundam Clin Pharmacol; 2007 Jun; 21(3):307-16. PubMed ID: 17521300
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole treatment does not affect the metabolism of caffeine.
Andersson T; Bergstrand R; Cederberg C; Eriksson S; Lagerström PO; Skånberg I
Gastroenterology; 1991 Oct; 101(4):943-7. PubMed ID: 1889718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
